FACTORS ASSOCIATED WITH INCREASED NORADRENALINE LEVELS IN SCHIZOPHRENIC-PATIENTS

被引:24
作者
KEMALI, D [1 ]
MAJ, M [1 ]
GALDERISI, S [1 ]
ARIANO, MG [1 ]
STARACE, F [1 ]
机构
[1] NAPLES UNIV, SCH MED 1, DEPT MED PSYCHOL & PSYCHIAT, I-80138 NAPLES, ITALY
关键词
noradrenaline; overarousal; schizophrenia;
D O I
10.1016/0278-5846(90)90063-M
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. 1. CSF NA levels were determined in a sample of DSM 111-diagnosed schizophrenics and in a non-psychiatric control group. Schizophrenics with NA levels above and below the median were compared with respect to several clinical historical neuropsychological and biological variables. 2. 2. Mean CSP NA levels were significantly higher in schizophrenics than in controls. 3. 3. Schizophrenics with high CSF NA levels as compared to those with low levels had significantly higher scores on the CPRS subscale for positive symptoms. Moreover in the former subgroup C-EEB alpha relative activity was significantly lower and C-EEG beta relative activity was significantly higher in frontal and central leads. Two of the three patients who had been never treated with neuroleptics, and three of the six patients who had been neuroleptic-free for more than four weeks had high CSF NA levels. 4. 4. These data support the relationship between increased CSF NA levels and the condition of overarousal of the schizophrenic patients, and suggest that prior neuroleptic treatment is not a major determinant of high CSF NA concentration in schizophrenics. © 1990.
引用
收藏
页码:49 / 59
页数:11
相关论文
共 66 条
[1]  
ACKENHEIL M, 1979, CATECHOLAMINES BASIC, V2, P1937
[2]   EFFECTS OF SULPIRIDE AND CHLORPROMAZINE ON AUTISTIC AND POSITIVE PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIC-PATIENTS - RELATIONSHIP TO DRUG CONCENTRATIONS [J].
ALFREDSSON, G ;
HARNRYD, C ;
WIESEL, FA .
PSYCHOPHARMACOLOGY, 1985, 85 (01) :8-13
[3]   NOREPINEPHRINE-DOPAMINE INTERACTIONS AND BEHAVIOR [J].
ANTELMAN, SM ;
CAGGIULA, AR .
SCIENCE, 1977, 195 (4279) :646-653
[4]  
ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
[5]   POSITIVE AND NEGATIVE SCHIZOPHRENIC SYMPTOMS AND THE ROLE OF DOPAMINE [J].
ASHCROFT, GW ;
BLACKWOOD, GW ;
BESSON, JAO ;
PALOMO, T ;
WARING, HL .
BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (MAR) :268-269
[6]  
AURIOL B, 1972, NOUV PRESSE MED, V1, P1439
[7]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[8]   DECREASE IN DOPAMINE, ITS METABOLITES AND NORADRENALINE IN CEREBROSPINAL-FLUID OF SCHIZOPHRENIC-PATIENTS AFTER WITHDRAWAL OF LONG-TERM NEUROLEPTIC TREATMENT [J].
BAGDY, G ;
PERENYI, A ;
FRECSKA, E ;
REVAI, K ;
PAPP, Z ;
FEKETE, MIK ;
ARATO, M .
PSYCHOPHARMACOLOGY, 1985, 85 (01) :62-64
[9]   INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIA [J].
BIRD, ED ;
SPOKES, EGS ;
IVERSEN, LL .
BRAIN, 1979, 102 (JUN) :347-360
[10]  
BIRD ED, 1979, SCIENCE, V204, P93, DOI 10.1126/science.432632